Vera Therapeutics Vera logo

News Releases

January 18, 2022

Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis

- Positive feedback from FDA to initiate Phase 3 trial of atacicept in patients with LN - BRISBANE, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients … Read more
January 4, 2022

Vera Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

BRISBANE, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that Marshall Fordyce, MD, founder … Read more
Top